Werewolf Therapeutics (NASDAQ:HOWL) Director Sells $21,256.67 in Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 34,847 shares of the stock in a transaction dated Tuesday, December 30th. The shares were sold at an average price of $0.61, for a total value of $21,256.67. Following the completion of the sale, the director owned 2,515,827 shares of the company’s stock, […]
3 Jan 00:20 · The Markets Daily